Illumina Posts 47 Percent Jump in Q1 Revenues

CEO Jay Flatley said that firm's sequencing revenues grew 80 percent over the first quarter of 2010, due in large part to broad adoption of the firm's HiSeq 2000.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories